Related Experiment Video
Updated: Aug 15, 2026

A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
Neurobehavioral effects of treatment for opiate withdrawal
M G Coyle1, A Ferguson, L Lagasse
1Department of Pediatrics, Brown Medical School, Women & Infants Hospital, 101 Dudley Street, Providence, Rhode Island 02905-2401, USA. coylem@southcoast.org
Insights
Adding phenobarbital to diluted tincture of opium (DTO) treatment significantly improved neurobehavioral scores in opiate-exposed infants. This dual treatment enhanced infant interaction, movement, and stress levels during early recovery.
Area of Science:
- Neonatal Abstinence Syndrome
- Neurobehavioral Development
- Pharmacological Interventions
Background:
- Infants exposed to opiates in utero often experience Neonatal Abstinence Syndrome (NAS).
- Current treatments for NAS, such as diluted tincture of opium (DTO), aim to manage withdrawal symptoms.
- The potential benefits of adjunctive therapies to DTO for improving infant neurobehavior require further investigation.
Purpose of the Study:
- To evaluate the efficacy of combined diluted tincture of opium (DTO) and phenobarbital therapy.
- To compare neurobehavioral outcomes in opiate-exposed infants receiving dual treatment versus DTO alone.
- To determine if combined therapy accelerates recovery from neonatal opiate withdrawal.
Main Methods:
- A partially randomized controlled trial was conducted.
- Infants were assigned to receive either DTO alone or DTO in combination with phenobarbital.
- Neurobehavioral assessments were performed during the initial three weeks of life.
Main Results:
- Infants receiving DTO and phenobarbital (n=17) demonstrated significantly better neurobehavioral scores compared to those receiving DTO alone (n=15).
- The dual-treatment group exhibited increased interactivity, smoother motor function, and reduced stress.
- These improvements suggest enhanced neurobehavioral organization in the first three weeks post-birth.
Conclusions:
- Combined DTO and phenobarbital therapy improves neurobehavioral organization in opiate-exposed infants.
- This dual treatment approach may facilitate a more rapid recovery from neonatal opiate withdrawal.
- Further research is warranted to confirm these findings and optimize treatment protocols for NAS.
Abstract:
A partially randomised, controlled trial was performed to test the hypothesis that opiate exposed infants treated with diluted tincture of opium (DTO) and phenobarbital would have better neurobehavioral scores than infants treated with DTO alone. Compared with those treated with DTO alone (n = 15), infants treated with DTO and phenobarbital (n = 17) were more interactive, had smoother movements, were easier to handle, and less stressed. Dual treatment results in improved neurobehavioral organisation during the first three weeks of life, which may indicate a more rapid recovery from opiate withdrawal.
Related Concept Videos
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

